ATI Pharmacology: Pharmacokinetics & Drug Actions Practice Exam
2026 |Questions |Answers |Rationales
1. Which phase of pharmacokinetics involves the movement of a drug from its
site of administration into the blood?
A. Distribution
B. Absorption
C. Metabolism
D. Excretion
Answer: B
Rationale: Absorption is the process of a drug moving from the site of administration into
the bloodstream. Distribution is movement to tissues, metabolism is enzymatic alteration,
and excretion is removal from the body.
2. A nurse is administering a drug that has a high first-pass effect. Which route
of administration should the nurse expect to result in the lowest bioavailability?
A. Sublingual
B. Intravenous
C. Subcutaneous
D. Oral
Answer: D
Rationale: Oral medications are absorbed in the GI tract and pass through the liver via the
portal vein. A high first-pass effect means a large portion of the drug is metabolized by the
liver before reaching systemic circulation.
,3. What is the primary site for drug metabolism in the human body?
A. Liver
B. Kidneys
C. Lungs
D. Small Intestine
Answer: A
Rationale: The liver is the primary organ for metabolism, primarily through the
cytochrome P450 enzyme system. The kidneys are primarily responsible for excretion.
4. If a drug has a half-life of 4 hours and a dose of 400 mg is given, how much of
the drug remains in the body after 8 hours?
A. 100 mg
B. 200 mg
C. 50 mg
D. 0 mg
Answer: A
Rationale: After one half-life (4 hours), 200 mg remains. After a second half-life (8 hours
total), half of that 200 mg remains, which is 100 mg.
5. Which term describes the process where a drug binds to a receptor and
produces a maximal therapeutic response?
A. Antagonist
B. Partial Agonist
C. Agonist
D. Competitive inhibitor
Answer: C
Rationale: An agonist is a drug that mimics the body’s own regulatory molecules and
activates receptors to produce a response.
, 6. A patient with a low serum albumin level is receiving a highly protein-bound
drug. The nurse should monitor for which effect?
A. Increased risk of toxicity
B. Decreased therapeutic effect
C. Delayed onset of action
D. Rapid excretion of the drug
Answer: A
Rationale: If albumin is low, there are fewer binding sites for the drug. This leads to more
free, active drug in the bloodstream, increasing the risk of toxicity.
7. The nurse monitors a patient’s GFR and creatinine clearance to assess the
function of which pharmacokinetic phase?
A. Excretion
B. Absorption
C. Metabolism
D. Distribution
Answer: A
Rationale: Renal function, measured by GFR and creatinine clearance, determines how
effectively the kidneys can excrete drugs from the body.
8. Which type of drug prevents receptor activation by endogenous compounds
or other drugs?
A. Potentiator
B. Agonist
C. Synergist
D. Antagonist
Answer: D
Rationale: Antagonists produce their effects by preventing receptor activation. They have
affinity for the receptor but lack intrinsic activity.
2026 |Questions |Answers |Rationales
1. Which phase of pharmacokinetics involves the movement of a drug from its
site of administration into the blood?
A. Distribution
B. Absorption
C. Metabolism
D. Excretion
Answer: B
Rationale: Absorption is the process of a drug moving from the site of administration into
the bloodstream. Distribution is movement to tissues, metabolism is enzymatic alteration,
and excretion is removal from the body.
2. A nurse is administering a drug that has a high first-pass effect. Which route
of administration should the nurse expect to result in the lowest bioavailability?
A. Sublingual
B. Intravenous
C. Subcutaneous
D. Oral
Answer: D
Rationale: Oral medications are absorbed in the GI tract and pass through the liver via the
portal vein. A high first-pass effect means a large portion of the drug is metabolized by the
liver before reaching systemic circulation.
,3. What is the primary site for drug metabolism in the human body?
A. Liver
B. Kidneys
C. Lungs
D. Small Intestine
Answer: A
Rationale: The liver is the primary organ for metabolism, primarily through the
cytochrome P450 enzyme system. The kidneys are primarily responsible for excretion.
4. If a drug has a half-life of 4 hours and a dose of 400 mg is given, how much of
the drug remains in the body after 8 hours?
A. 100 mg
B. 200 mg
C. 50 mg
D. 0 mg
Answer: A
Rationale: After one half-life (4 hours), 200 mg remains. After a second half-life (8 hours
total), half of that 200 mg remains, which is 100 mg.
5. Which term describes the process where a drug binds to a receptor and
produces a maximal therapeutic response?
A. Antagonist
B. Partial Agonist
C. Agonist
D. Competitive inhibitor
Answer: C
Rationale: An agonist is a drug that mimics the body’s own regulatory molecules and
activates receptors to produce a response.
, 6. A patient with a low serum albumin level is receiving a highly protein-bound
drug. The nurse should monitor for which effect?
A. Increased risk of toxicity
B. Decreased therapeutic effect
C. Delayed onset of action
D. Rapid excretion of the drug
Answer: A
Rationale: If albumin is low, there are fewer binding sites for the drug. This leads to more
free, active drug in the bloodstream, increasing the risk of toxicity.
7. The nurse monitors a patient’s GFR and creatinine clearance to assess the
function of which pharmacokinetic phase?
A. Excretion
B. Absorption
C. Metabolism
D. Distribution
Answer: A
Rationale: Renal function, measured by GFR and creatinine clearance, determines how
effectively the kidneys can excrete drugs from the body.
8. Which type of drug prevents receptor activation by endogenous compounds
or other drugs?
A. Potentiator
B. Agonist
C. Synergist
D. Antagonist
Answer: D
Rationale: Antagonists produce their effects by preventing receptor activation. They have
affinity for the receptor but lack intrinsic activity.
